Lionel M. Nelson

Fondatore presso Apneon, Inc.

Consumer Services

Health Technology

Profilo

Lionel M.
Nelson has been Medical Director of Apneon, Inc. since 2003.
He is a Clinical Associate Professor at the Stanford University School of Medicine.
Dr. Nelson served in the US Army Special Operations as a Colonel.
He received an undergraduate degree in Physics from the City University of New York and a Medical degree from the Yale University School of Medicine.
Dr. Nelson completed his post-graduate Surgical and Otolaryngologic training at the University of California, San Diego, and Stanford.

Posizioni attive di Lionel M. Nelson

Società	Posizione	Inizio
Apneon, Inc. Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA.	Fondatore	16/02/2010

Tutte le posizioni attive di Lionel M. Nelson

Formazione di Lionel M. Nelson

Yale University	Doctorate Degree
City University of New York	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Lionel M. Nelson

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Apneon, Inc. Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA.	Health Technology